Delivery Order SPE2DB22D3004-SPE2DB25FSB17
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Jardiance 25 mg tablets (90-count units) under a firm fixed price contract valued at $10,700.20. The order, with an ultimate completion date of July 21, 2025, was competitively awarded without set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical supply delivery to support federal medical procurement needs....
- The Defense Logistics Agency awarded a delivery order valued at $15,404.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order utilizes firm fixed pricing and is sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal healthcare operations....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract valued at $8,243.58. The order, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, represents a non-competitive award executed without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery, leveraging its...
- The Defense Logistics Agency awarded a delivery order valued at $12,690.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $48,933.00 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is performed at the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a small transaction within AmerisourceBergen's broader federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,468.68 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on August 25, 2025, with completion scheduled for August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $22,046.36 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,844.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, which is not set-aside, represents a single pharmaceutical procurement under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $6,475.44. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and specifies...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $15,108.86 under a firm fixed-price contract type. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a competitive award with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSB17Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count quantity under a firm fixed-price contract valued at $1,484.78. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive, direct procurement utilizing the company's existing pharmaceutical supply agreement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen maintains an extensive portfolio of medications and medical supplies supporting military and veteran healthcare systems. The IDC enables flexible fulfillment of pharmaceutical needs across multiple therapeutic domains, serving defense and civilian federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/18/25 |